- Home
- LGND vs CLM Comparison
LGND vs CLM Comparison
Compare LGND & CLM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGND
- CLM
- Stock Information
- Founded
- LGND 1987
- CLM 1987
- Country
- LGND United States
- CLM United States
- Employees
- LGND N/A
- CLM N/A
- Industry
- LGND Biotechnology: Pharmaceutical Preparations
- CLM Finance/Investors Services
- Sector
- LGND Health Care
- CLM Finance
- Exchange
- LGND Nasdaq
- CLM Nasdaq
- Market Cap
- LGND 2.0B
- CLM 1.9B
- IPO Year
- LGND 1992
- CLM N/A
- Fundamental
- Price
- LGND $108.55
- CLM $6.98
- Analyst Decision
- LGND Strong Buy
- CLM
- Analyst Count
- LGND 7
- CLM 0
- Target Price
- LGND $144.67
- CLM N/A
- AVG Volume (30 Days)
- LGND 116.1K
- CLM 1.4M
- Earning Date
- LGND 05-08-2025
- CLM 01-01-0001
- Dividend Yield
- LGND N/A
- CLM 18.74%
- EPS Growth
- LGND N/A
- CLM N/A
- EPS
- LGND N/A
- CLM N/A
- Revenue
- LGND $167,133,000.00
- CLM N/A
- Revenue This Year
- LGND $16.47
- CLM N/A
- Revenue Next Year
- LGND $19.44
- CLM N/A
- P/E Ratio
- LGND N/A
- CLM N/A
- Revenue Growth
- LGND 27.28
- CLM N/A
- 52 Week Low
- LGND $69.17
- CLM $6.25
- 52 Week High
- LGND $129.90
- CLM $8.84
- Technical
- Relative Strength Index (RSI)
- LGND 53.94
- CLM 43.40
- Support Level
- LGND $101.24
- CLM $6.57
- Resistance Level
- LGND $111.39
- CLM $7.35
- Average True Range (ATR)
- LGND 5.67
- CLM 0.32
- MACD
- LGND 0.82
- CLM 0.01
- Stochastic Oscillator
- LGND 84.05
- CLM 68.91
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
About CLM Cornerstone Strategic Value Fund Inc. New
Cornerstone Strategic Value Fund Inc is a closed-end management investment company. The fund's objective is to seek long-term capital appreciation through investments in equity securities of U.S. and non-U.S. companies. It invests in various sectors, which include financials, information technology, healthcare, consumer discretionary, industrials, utilities, energy, telecommunication services, materials, and other sectors.